SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-22-046705
Filing Date
2022-02-18
Accepted
2022-02-18 16:59:46
Documents
7
Effectiveness Date
2022-02-18

Document Format Files

Seq Description Document Type Size
1 S-8 d265449ds8.htm S-8 56863
2 EX-5.1 d265449dex51.htm EX-5.1 7953
3 EX-23.1 d265449dex231.htm EX-23.1 1498
4 EX-99.4 d265449dex994.htm EX-99.4 149148
5 EX-99.5 d265449dex995.htm EX-99.5 63534
6 EX-FILING FEES d265449dexfilingfees.htm EX-FILING FEES 16645
7 GRAPHIC g265449g0217104634720.jpg GRAPHIC 2529
  Complete submission text file 0001193125-22-046705.txt   300298
Mailing Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-779-3100
Poseida Therapeutics, Inc. (Filer) CIK: 0001661460 (see all company filings)

IRS No.: 472846548 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-262869 | Film No.: 22653650
SIC: 2836 Biological Products, (No Diagnostic Substances)